Right now, in the right way: U. S. Food and Drug Administration’s expanded access program and patient rights

Lignende værker

• 2276 Development of the expanded access oversight committee at Michigan Medicine
  af: Weatherwax, Kevin, et al.
  Udgivet: (2018)
• Access to Investigational Drugs: FDA Expanded Access Programs or “Right‐to‐Try” Legislation?
  af: Holbein, M. E. Blair, et al.
  Udgivet: (2015)
• The Critical Role of Medical Institutions in Expanding Access to Investigational Interventions
  af: Spector-Bagdady, Kayte, et al.
  Udgivet: (2019)
• Role of CTSA institutes and academic medical centers in facilitating preapproval access to investigational agents and devices during the COVID-19 pandemic
  af: Gravelin, Misty, et al.
  Udgivet: (2021)
• Neighborhood characteristics of expanded access patients at an academic referral center
  af: Misty Gravelin, et al.
  Udgivet: (2025-01-01)